Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Lucy Kerr et al. We have previously demonstrated that ivermectin used as prophylaxis for coronavirus disease 2019 (COVID- 19), irrespective of the regularity, in a strictly controlled citywide program in Southern Brazil (Itajaí, Brazil), was associated with reductions in COVID-19 infection, hospitalization, and mortality rates. In this study, our objective was to determine if the […]

New Study Shows Ivermectin Can Reduce Chance of Death by 92%

Steve Kirsch A new large prospective observational study of 88,000 people shows ivermectin works; the greater the dose, the better it works. There were 0 COVID hospitalizations in the group of regular ivermectin users compared to 10 in the irregular user group. How does the WHO react? They ignore it of course! The WHO has not updated […]

Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacterial to Boost Immunity

white and blue round decor

Sabine Hazan Ivermectin is an anti-parasitic agent that has gained attention as a potential COVID-19 therapeutic. It is a compound of the type Avermectin, which is a fermented by-product of Streptomyces avermitilis. Bifidobacterium is a member of the same phylum as Streptomyces spp., suggesting it may have a symbiotic relation with Streptomyces. Decreased Bifidobacterium levels are observed in COVID-19 susceptibility states, including old […]

New Study Shows Ivermectin Can Reduce Chance of Death by 92%

Steve Kirsch A new large prospective observational study of 88,000 people shows ivermectin works; the greater the dose, the better it works. How does the WHO react? They ignore it of course! The WHO has not updated their treatment guideline for Ivermectin in over 1 year.

Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity

Sabine Hazan Ivermectin is an anti-parasitic agent that has gained attention as a potential COVID-19 therapeutic. It is a compound of the type Avermectin, which is a fermented by-product of Streptomyces avermitilis. Bifidobacterium is a member of the same phylum as Streptomyces spp., suggesting it may have a symbiotic relation with Streptomyces. Decreased Bifidobacterium levels are observed in COVID-19 susceptibility states, including old […]